---
title: "Fulcrum CFO Alan Musso takes over as principal accounting officer after Tourangeau exit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295409058.md"
description: "Fulcrum Therapeutics announced that CFO Alan Musso will assume the role of principal accounting officer effective August 7, 2026, following the departure of Greg Tourangeau."
datetime: "2026-08-10T12:44:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295409058.md)
  - [en](https://longbridge.com/en/news/295409058.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295409058.md)
generator: "portal-rs"
---

# Fulcrum CFO Alan Musso takes over as principal accounting officer after Tourangeau exit

-   Fulcrum Therapeutics set Aug. 7, 2026 as the departure date for Vice President, Finance Greg Tourangeau, the principal accounting officer. \* Chief Financial Officer Alan Musso was appointed principal accounting officer effective Aug. 7, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-341385), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [FULC.US](https://longbridge.com/en/quote/FULC.US.md)

## Related News & Research

- [Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares](https://longbridge.com/en/news/293268525.md)
- [Fulcrum Therapeutics director Alan Ezekowitz disposes of 18,000 common shares for $65,614](https://longbridge.com/en/news/291330614.md)
- [BE: Revenue rose 138% YoY as margins expanded and FY2026 guidance was raised again](https://longbridge.com/en/news/302787538.md)
- [Nokia Q3 profit rises 95% to EUR 156 million](https://longbridge.com/en/news/302649426.md)
- [TTMI: Record Q3 results and strong backlog support a $6.5–6.75B FY2027 sales outlook](https://longbridge.com/en/news/302694237.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**